Carbon monoxide: Vascular therapeutic for the future

Vascular

Volumn 17, Issue SUPPL. 1, 2009, Pages

  Tzeng, Edith ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Carbon monoxide; Heme oxygenase; Inflammation; Intimal hyperplasia

Indexed keywords

CARBON MONOXIDE; CARBOXYHEMOGLOBIN; HEME OXYGENASE 1; NITRIC OXIDE; OXYGEN; HEME OXYGENASE;

AMBIENT AIR; ANTIINFLAMMATORY ACTIVITY; ARTERY INTIMA PROLIFERATION; BLOOD VESSEL INJURY; CAROTID ARTERY INJURY; CELL PROTECTION; FATALITY; HUMAN; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; ANIMAL; ANIMAL MODEL; BALLOON DILATATION; FORECASTING; HYPERPLASIA; INTIMA; METABOLISM; PATHOLOGY;

ANIMALS; BALLOON DILATATION; CARBON MONOXIDE; FORECASTING; HEME OXYGENASE (DECYCLIZING); HUMANS; HYPERPLASIA; MODELS, ANIMAL; TUNICA INTIMA;

EID: 70349229902     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.2310/6670.2008.00090     Document Type: Review

References (87)

1. Von Berg R. Toxicology update. Carbon monoxide. J Appl Toxicol 1999;19:379-86.
2. Sjostrand T. Endogenous production of carbon monoxide in man under normal and pathophysiological conditions. Scand J Clin Lab Invest 1949;1:201-14.
3. Sjostrand T. The formation of carbon monoxide by the decomposition of hemoglobin in vivo. Acta Physiol Scand 1952; 26:338-44.
4. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 1968;61:748-55.
5. Trakshel GM, Kutty RK, Maines MD. Purification and characterization of the major constitutive form of testicular heme oxygenase. J Biol Chem 1986;261:11131-7.
6. Zakhary R, Gaine SP, Dinerman JL, et al. Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci U S A 1996;93:795-8.
7. Maines MD, Trakshel GM, Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. J Biol Chem 1986;261:411-9.
8. Da Silva J-L, Zand BA, Yang LM, et al. Hemeoxygenase isoformspecific expression and distribution in rat kidney. Kidney Int 2001; 59:1448-57.
9. Gibbs L, Willis D. Morgan MJ. The identification and expression of heme oxygenase-2 alternative transcripts in the mouse. Gene 1998;221:171-7.
10. Stanford SJ, Walters MJ, Hislop AA, et al. Heme oxygenase is expressed in human pulmonary artery smooth muscle where carbon monoxide has an antiproliferative role. Eur J Pharmacol 2003;473:135-41.
11. Ryter SW, Alam J, Choi AMKC. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006;86:583-650.
12. Tenhunen R, Marver H, Schmid R. Microsomal heme oxygenase, characterization of the enzyme. J Biol Chem 1969;244: 6388-94.
13. Tenhunen R, Marver H, Schmid R. The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin. J Lab Clin Med 1970;75:410-21.
14. Abraham NG. Molecular regulation-biological role of heme in hematopoiesis. Blood Rev 1991;5:19-28.
15. Wagener FADTG, Volke H-D, Willis D, et al. Different faces of the heme-heme oxygenase system in inflammation. Pharmcol Rev 2003;55:551-71.
16. Hartsfield CL, Alam J, Choi AM. Differential signaling pathways of HO-1 gene expression in pulmonary and systemic vascular cells. Am J Physiol Lung Cell Mol Physiol 1999;277:L1133-41.
17. Lee PJ, Jiang BH, Chin BY, et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997;272:5375-81.
18. Ryter SW, Xi S, Hartsfield CL, Choi AM. Mitogen activated protein kinase (MAPK) pathway regulates heme oxygenase-1 gene expression by hypoxia in vascular cells. Antioxid Redox Signal 2002;4:587-92.
19. Gomer CJ, Luna M, Ferrario A, Rucker N. Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or photofrin II incubation. Photochem Photobiol 1991;53:275-9.
20. Keyse SM, Tyrrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci U S A 1989;86:99-103.
21. Maines MD, Kappas A. Metals as regulators of heme metabolism. Science 1977;198:1215-21.
22. Caltabiano MM, Koestler TP, Poste G, et al. Induction of 32- and 34-kDa stress proteins by sodium arsenite, heavy metals and thiolreactive agents. J Biol Chem 1986;261:13381-6.
23. Masuya Y, Hioki K, Tokunaga R, Taketani S. Involvement of the tyrosine phosphorylation pathway in induction of human heme oxygenase-1 by hemin, sodium aresnite, and cadmium chloride. J Biochem 1998;124:628-33.
24. Chen K, Maines MD. Nitric oxide induces heme oxygenase-1 via mitogen-activated kinase ERK and p38. Cell Mol Biol 2000;46:609-17.
25. Durante W, Kroll MH, Christodoulides N, et al. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 1997;80: 557-64.
26. Hartsfield CL, Alam J, Cook JL, Choi AM. Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. Am J Physiol Lung Cell Mol Physiol 1997;273:L980-8.
27. Terry CM, Clikeman JA, Hoidal JR, Callahan KS. Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells. Am J Physiol Heart Circ Physiol 1998;274:H883-91.
28. Rizzardini M, Terao M, Falciani F, Cantoni L. Cytokine induction of haem oxygenase mRNA in mouse liver. Interleukin 1 transcriptionally activates the haem oxygenase gene. Biochem J 1993;290:343-7.
29. Lee TS, Chau LY. Heme oxygenase-1 mediates the antiinflammatory effect of interleukin-10 in mice. Nat Med 2002;8: 240-6.
30. Camhi SL, Alam J, Otterbein L, et al. Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation. Am J Respir Cell Mol Biol 1995;13:387-98.
31. Kurata S, Matsumoto M, Tsuji Y, Nakajima H. Lipopolysaccharide activates transcription of the heme oxygenase gene in mouse M1 cells through oxidative activation of nuclear factor kappa B. Eur J Biochem 1996;239:566-71.
32. Rizzardini M, Carelli M, Cabello Porras MR, Cantoni L. Mechanisms of endotoxin-induced haem oxygenase mRNA accumulation in mouse liver: synergism by glutathione depletion and protection by N-acetylcysteine. Biochem J 1994;304:477-83.
33. Sato H, Siow RCM, Bartless S, et al. Expression of stress proteins heme oxygenase-1 and -2 in acute pancreatitis and pancreatic islet βTC3 and acinar AR42J cells. FEBS Lett 1997;405:219-23.
34. Nakamichi I, Habtezion A, Zhong B, et al. Hemin-activated macrophages home to the pancreas and protein from acute pancreatitis via heme oxygenase-1 induction. J Clin Invest 2005; 115:3007-14.
35. Harju T, Soini Y, Paakko P, Kinnula VL. Up-regulation of heme oxygenase-1 in alveolar macrophages of newly diagnosed asthmatics. Resp Med 2002;96:418-23.
36. high regulatory T cells suppress allergic airway inflammation. J Immunol 2006;177:5936-45.
37. Slebos D-J, Ryter SW, van der Toorn M, et al. Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am J Respir Cell Mol Biol 2007;36:409-17.
38. Maestrelli P, Messlemani AG, de Fina O, et al. Increased expression of heme oxygenase (HO)-1 in alveolar spaces and HO-2 in alveolar walls and smokers. Am J Respir Crit Care Med 2001;164: 1508-13.
39. Chung SW, Liu X, Macias AA, et al. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest 2008;118:239-47.
40. Fujii H, Takahashi T, Nakahira K, et al. Protective role of heme oxygenase-1 in the intestinal tissue injury in an experimental model of sepsis. Lab Invest 2003;31:893-902.
41. Siow RC, Sato H, Mann GE. Heme oxygenase-carbon monoxide signaling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res 1999;41:385-94.
42. Wang LJ, Lee TS, Lee FY, et al. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 1998;152:711-20.
43. Yet SF, Layne MD, Liu X, et al. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 2003;17:1759-61.
44. Yachie A, Niida Y, Wada T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999;103:129-35.
45. Kawashima A, Oda Y, Yachie A, et al. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol 2002;33:125-30.
46. Duckers HJ, Boehm M, True AL, et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001;7: 693-8.
47. Tulis DA, Durante W, Liu XM, et al. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 2001;104:2710-5.
48. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low-density lipoprotein lipid peroxidation. J Biol Chem 1994;269: 16712-9.
49. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin bound bilirubin. Proc Natl Acad Sci U S A 1987;84:5918-22.
50. Stocker R, Peterhans E. Synergistic interaction between vitamin E and the bile pigments bilirubin and biliverdin. Biochim Biophys Acta 1989;1002:238-44.
51. Clark JE, Foresti R, Green CJ, Motterlini R. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J 2000;348:615-9.
52. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A 2002; 99:16093-8.
53. Wang WW, Smith DL, Zucker SD. Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 2004;40:424-33.
54. Wang HD, Yamaya M, Okinaga S, et al. BIlirubin ameliorates bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med 2002;165:406-11.
55. Kitamura Y, Ishida Y, Takata K, et al. Hyperbilirubinemia protects against focal ischemia in rats. J Neurosci Res 2003;71:544-50.
56. Nakao A, Neto JS, Kanno S, et al. Protection against ischemia/ reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 2005;5: 282-91.
57. Fondevila C, Shen XD, Tsuchiyashi S, et al. Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 2004;40:1333-41.
58. Nakao A, Murase N, Ho C, et al. Biliverdin administration prevents the formation of intimal hyperplasia induced by vascular injury. Circulation 2005;112:587-91.
59. Schwertner HA, Jackson WG, Tolan G. Association of lower serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994;40:18-23.
60. Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial diease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol 2008; 28:166-72.
61. Denninger JW, Marletta MA. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim Biophys Acta 1999;1411:334-50.
62. Furchgott RF, Jothianandan D. Endothelium-dependent and - independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 1991;28:52-61.
63. Otterbein LE, Zuckerbraun BS, Haga M, et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003;9:183-90.
64. Raman KG, Barbato JE, Ifedigbo E, et al. Inhaled carbon monoxide inhibits intimal hyperplasia and provides added benefit with nitric oxide. J Vasc Surg 2006;44:151-8.
65. Ramlawi B, Scott JR, Feng J, et al. Inhaled carbon monoxide prevents graft-induced intimal hyperplasia in swine. J Surg Res 2007;138:121-7.
66. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-36.
67. Zuckerbraun BS, Yoke Chin B, Wegiel B, et al. Carbon monoxide reverses established pulmonary hypertension. J Exp Med 2006;203: 2109-19.
68. Coburn RF, Forman HJ. Carbon monoxide toxicity. In: Fishman AP, Farhi LE, Tenney SM, editors. Handbook of physiology. The respiratory system. Gas exchange. Bethesda (MD): America Physiological Society; 1987. p. 439.
69. Zuckerbraun BS, Billiar TR, Otterbein SL, et al. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase-1. J Exp Med 2003;198:1707-16.
70. Brouard S, Otterbein LE, Anrather J, et al. Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis. J Exp Med 2000;192:1015-26.
71. Morita T, Mitsialis SA, Koike H, et al. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 1997;272:32804-9.
72. Chin BY, Jiang G, Wegiel B, et al. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci U S A 2007;104:5109-14.
73. Wang R, Wu L. The chemical modification of calcium-dependent potassium channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem 1997;272:8222-6.
74. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has antiinflammatory effects involving the motgen-activated protein kinase pathway. Nat Med 2000;6:422-8.
75. Otterbein LE, Mantell L, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 1999;276:L688-94.
76. Kaizu T, Nakao A, Tsung A, et al. Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation. Surgery 2005;138:229-35.
77. Nakao A, Kimizuka K, Stolz DB, et al. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol 2003;163:1587-98.
78. Kohmoto J, Nakao A, Stolz DB, et al. Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway. Am J Transplant 2007;7:1-11.
79. Nakao A, Toyokawa H, Abe M, et al. Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T-cell responses. Transplantation 2006;81:220-30.
80. Motterlini R, Clark JE, Foresti R, et al. Carbon monoxide releasing molecules: characterization of biochemical and vascular activities. Circ Res 2002;90:E17-24.
81. Motterlini R, Sawle P, Hammad J, et al. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 2005;19:284-6.
82. Masini E, Vannacci A, Failli P, et al. A carbon monoxide-releasing molecule (CORM-3) abrogates polymorphonuclear granulocyteinduced activation of endothelial cells and mast cells. FASEB J 2008;22:107-10.
83. Clark JE, Naughton P, Shurey S, et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003;93:e2-8.
84. Raub JA, Mathieu-Nolf M, Hampson NB, Thom ST. Carbon monoxide poisoning - a public health perspective. Toxicology 2000;145:1-14.
85. Occupational safety and health guideline for carbon monoxide, Available at: http://www.osha.gov/SLTC/healthguidelines/carbonmonoxide/ recognition.html (accessed October 9, 2007).
86. Mayr FB, Spiel A, Leitner J, et al. Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med 2005;171:354-60.
87. Gandini C, Castoldi AF, Candura SM, et al. Carbon monoxide cardiotoxicity. Clin Toxicol 2001;39:35-44.